[
  {
    "ts": "2025-12-16T13:25:00+00:00",
    "headline": "2 Recession-Proof Stocks to Watch in December",
    "summary": "These companies have stood the test of time and survived many previous recessions.",
    "url": "https://www.fool.com/investing/2025/12/16/2-recession-proof-stocks-to-watch-in-december/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "3a624b60-7bde-333c-9210-8d9c5258a784",
      "content": {
        "id": "3a624b60-7bde-333c-9210-8d9c5258a784",
        "contentType": "STORY",
        "title": "2 Recession-Proof Stocks to Watch in December",
        "description": "",
        "summary": "These companies have stood the test of time and survived many previous recessions.",
        "pubDate": "2025-12-16T13:25:00Z",
        "displayTime": "2025-12-16T13:25:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/bab334d437f25c3220d45d5e00c499ba",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Someone walking down the aisle in a retail store.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CCg0QrxgGRQWOvriUqhbdQ--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/bab334d437f25c3220d45d5e00c499ba.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ikk6_J4g4.pBleVB9NF1mA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/bab334d437f25c3220d45d5e00c499ba.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/16/2-recession-proof-stocks-to-watch-in-december/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/2-recession-proof-stocks-watch-132500152.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-16T13:05:00+00:00",
    "headline": "S&P Global Adds Hubert Joly to its Board of Directors",
    "summary": "S&P Global (NYSE: SPGI) announced today that its Board of Directors has approved the addition of Mr. Hubert Joly to the Board, effective January 2, 2026.",
    "url": "https://finance.yahoo.com/news/p-global-adds-hubert-joly-130500058.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "48269b55-df39-3483-87c7-91f527b57aab",
      "content": {
        "id": "48269b55-df39-3483-87c7-91f527b57aab",
        "contentType": "STORY",
        "title": "S&P Global Adds Hubert Joly to its Board of Directors",
        "description": "",
        "summary": "S&P Global (NYSE: SPGI) announced today that its Board of Directors has approved the addition of Mr. Hubert Joly to the Board, effective January 2, 2026.",
        "pubDate": "2025-12-16T13:05:00Z",
        "displayTime": "2025-12-16T13:05:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/31ec38d589403c8b14ea2089279ac1a0",
          "originalWidth": 400,
          "originalHeight": 155,
          "caption": "S&P Global Logo (PRNewsfoto/S&P Global)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4nDOl6Z9Dw52paTkezIObg--~B/aD0xNTU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/31ec38d589403c8b14ea2089279ac1a0.cf.webp",
              "width": 400,
              "height": 155,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oqb3.aYA18Vr1_cWuu7mYQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/31ec38d589403c8b14ea2089279ac1a0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/p-global-adds-hubert-joly-130500058.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/p-global-adds-hubert-joly-130500058.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SPGI"
            },
            {
              "symbol": "RL"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-16T13:00:00+00:00",
    "headline": "Cradle AI-powered protein engineering platform serving six of top 25 pharma leaders",
    "summary": "Cradle, an enterprise-grade AI software platform, today announced a series of milestones that signal a new phase of growth. The company saw rapid adoption across the pharma industry, with Cradle now running 50+ projects and powering drug discovery programs for six of the top 25 big pharma companies, including Johnson & Johnson, Abbvie, and Novo Nordisk. To continue expanding product capabilities and meet surging global demand, the company has doubled headcount across all departments and expanded",
    "url": "https://finance.yahoo.com/news/cradle-ai-powered-protein-engineering-130000674.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "2b5e2404-deba-30dd-b78e-a266f3a1eea7",
      "content": {
        "id": "2b5e2404-deba-30dd-b78e-a266f3a1eea7",
        "contentType": "STORY",
        "title": "Cradle AI-powered protein engineering platform serving six of top 25 pharma leaders",
        "description": "",
        "summary": "Cradle, an enterprise-grade AI software platform, today announced a series of milestones that signal a new phase of growth. The company saw rapid adoption across the pharma industry, with Cradle now running 50+ projects and powering drug discovery programs for six of the top 25 big pharma companies, including Johnson & Johnson, Abbvie, and Novo Nordisk. To continue expanding product capabilities and meet surging global demand, the company has doubled headcount across all departments and expanded",
        "pubDate": "2025-12-16T13:00:00Z",
        "displayTime": "2025-12-16T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/fc40123aaedbadb35b9ad3d93071a1c0",
          "originalWidth": 400,
          "originalHeight": 121,
          "caption": "Cradle",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rYz7kD7r_0_sMNyo5ZE5Cw--~B/aD0xMjE7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/fc40123aaedbadb35b9ad3d93071a1c0.cf.webp",
              "width": 400,
              "height": 121,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J2JpHMYTHST9tL2siQaBYw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/fc40123aaedbadb35b9ad3d93071a1c0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cradle-ai-powered-protein-engineering-130000674.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cradle-ai-powered-protein-engineering-130000674.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-16T23:03:41+00:00",
    "headline": "Stock Market Today, Dec. 16: Pfizer Falls After Cutting 2025 Revenue Forecast",
    "summary": "Today, Dec. 16, 2025, Pfizer's shrinking COVID cash flows could mean little growth next year as M&A bets will take time to deliver.",
    "url": "https://www.fool.com/coverage/stock-market-today/2025/12/16/stock-market-today-dec-16-pfizer-falls-after-cutting-2025-revenue-forecast/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "82287df5-21cd-3774-b7ff-3f7da26379c6",
      "content": {
        "id": "82287df5-21cd-3774-b7ff-3f7da26379c6",
        "contentType": "STORY",
        "title": "Stock Market Today, Dec. 16: Pfizer Falls After Cutting 2025 Revenue Forecast",
        "description": "",
        "summary": "Today, Dec. 16, 2025, Pfizer's shrinking COVID cash flows could mean little growth next year as M&A bets will take time to deliver.",
        "pubDate": "2025-12-16T23:03:41Z",
        "displayTime": "2025-12-16T23:03:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/b2266bf4e5454ef1a196b91a1f82ea1a",
          "originalWidth": 1401,
          "originalHeight": 1251,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/M2MzQpciI2zqH3bt4p6Z4Q--~B/aD0xMjUxO3c9MTQwMTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/motleyfool.com/b2266bf4e5454ef1a196b91a1f82ea1a.cf.webp",
              "width": 1401,
              "height": 1251,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/a1lMjbUUZQTJ4b4evRUbQw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/b2266bf4e5454ef1a196b91a1f82ea1a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/coverage/stock-market-today/2025/12/16/stock-market-today-dec-16-pfizer-falls-after-cutting-2025-revenue-forecast/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/stock-market-today-dec-16-230341600.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-16T18:01:29+00:00",
    "headline": "Pharma M&A deal value up 31% YoY in 2025YTD amid return of mega-deals",
    "summary": "Large M&A transactions and bidding wars for Metsera and Avadel announced in H2 2025 reflect a need for large pharma companies to replenish pipelines through M&A ahead of looming patent cliffs.",
    "url": "https://www.pharmaceutical-technology.com/analyst-comment/pharma-ma-deal-value-2025-ytd-mega-deals/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "c91e3306-a012-3e3e-8b18-0d74acf709ef",
      "content": {
        "id": "c91e3306-a012-3e3e-8b18-0d74acf709ef",
        "contentType": "STORY",
        "title": "Pharma M&A deal value up 31% YoY in 2025YTD amid return of mega-deals",
        "description": "",
        "summary": "Large M&A transactions and bidding wars for Metsera and Avadel announced in H2 2025 reflect a need for large pharma companies to replenish pipelines through M&A ahead of looming patent cliffs.",
        "pubDate": "2025-12-16T18:01:29Z",
        "displayTime": "2025-12-16T18:01:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/0baa429c1961bf5c160a985846d2ddc9",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Bidding wars emerged in 2025 between Pfizer and Novo Nordisk for obesity and metabolic diseases drug developer Metsera. Credit: PeopleImages via Shutterstock.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YYsMthE8vREBatyoHi10PQ--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/0baa429c1961bf5c160a985846d2ddc9.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/D6S4wOQQG30UF8dCMQXHlA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/0baa429c1961bf5c160a985846d2ddc9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/analyst-comment/pharma-ma-deal-value-2025-ytd-mega-deals/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pharma-m-deal-value-31-180129165.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "SNY"
            },
            {
              "symbol": "BPMC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-16T14:17:00+00:00",
    "headline": "3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most",
    "summary": "Healthcare behemoths, including the biggest name of them all, are increasing their dividends. Additionally, AMGN's dividend yield now sits solidly above 3%.",
    "url": "https://www.marketbeat.com/stock-ideas/3-healthcare-giants-just-raised-dividendsheres-who-pays-the-most/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "f693d6f5-2b2d-3ba9-8423-6620eac02a6a",
      "content": {
        "id": "f693d6f5-2b2d-3ba9-8423-6620eac02a6a",
        "contentType": "STORY",
        "title": "3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most",
        "description": "",
        "summary": "Healthcare behemoths, including the biggest name of them all, are increasing their dividends. Additionally, AMGN's dividend yield now sits solidly above 3%.",
        "pubDate": "2025-12-16T14:17:00Z",
        "displayTime": "2025-12-16T14:17:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/9fee6a58a220fb560af7cd812a39b361",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Stacks of gold coins forming an upward arrow beside a lab beaker and heart-rate icon.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/n1X4uebG0cR05r1lyiRQEg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/9fee6a58a220fb560af7cd812a39b361.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MykO9YhpdmTnvq_8P6dTyg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/9fee6a58a220fb560af7cd812a39b361.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/stock-ideas/3-healthcare-giants-just-raised-dividendsheres-who-pays-the-most/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-healthcare-giants-just-raised-141700337.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "SYK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-16T12:03:00+00:00",
    "headline": "Pfizer Adds to Its Big Bet on Weight Loss Drugs",
    "summary": "A month after acquiring obesity biotech Metsera, Pfizer's expanding in the weight loss drug market after signing a licensing agreement for a weight loss pill.",
    "url": "https://www.marketbeat.com/originals/pfizer-adds-to-its-big-bet-on-weight-loss-drugs/?utm_source=yahoofinance&utm_medium=yahoofinance",
    "source": "MarketBeat",
    "provider": "yfinance",
    "raw": {
      "id": "2a984f70-2f43-39e2-901b-38f4848d3dc4",
      "content": {
        "id": "2a984f70-2f43-39e2-901b-38f4848d3dc4",
        "contentType": "STORY",
        "title": "Pfizer Adds to Its Big Bet on Weight Loss Drugs",
        "description": "",
        "summary": "A month after acquiring obesity biotech Metsera, Pfizer's expanding in the weight loss drug market after signing a licensing agreement for a weight loss pill.",
        "pubDate": "2025-12-16T12:03:00Z",
        "displayTime": "2025-12-16T12:03:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/marketbeat_955/44fcc0338a641fcbb0eff1772200ab5e",
          "originalWidth": 1200,
          "originalHeight": 675,
          "caption": "Pfizer-branded beaker filled with blue liquid in a bright, modern laboratory.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YqRsnX_YhH3igP6M4KHXrw--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/marketbeat_955/44fcc0338a641fcbb0eff1772200ab5e.cf.webp",
              "width": 1200,
              "height": 675,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CS049xxA5qcHmH7krl1BAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/marketbeat_955/44fcc0338a641fcbb0eff1772200ab5e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MarketBeat",
          "url": "https://www.marketbeat.com/"
        },
        "canonicalUrl": {
          "url": "https://www.marketbeat.com/originals/pfizer-adds-to-its-big-bet-on-weight-loss-drugs/?utm_source=yahoofinance&utm_medium=yahoofinance",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-adds-big-bet-weight-120300213.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-16T10:38:30+00:00",
    "headline": "J&J Snack Foods to close 3 manufacturing sites in business revamp",
    "summary": "The Icee maker expects to accrue $20 million in annualized savings from a business transformation plan aimed at simplifying production and optimizing distribution.",
    "url": "https://www.supplychaindive.com/news/J-j-snack-foods-manufacturing-plant-closures-distribution-optimization-project-apollo/807916/",
    "source": "Supply Chain Dive",
    "provider": "yfinance",
    "raw": {
      "id": "95ac0a34-663f-3530-9f49-235e3097d091",
      "content": {
        "id": "95ac0a34-663f-3530-9f49-235e3097d091",
        "contentType": "STORY",
        "title": "J&J Snack Foods to close 3 manufacturing sites in business revamp",
        "description": "",
        "summary": "The Icee maker expects to accrue $20 million in annualized savings from a business transformation plan aimed at simplifying production and optimizing distribution.",
        "pubDate": "2025-12-16T10:38:30Z",
        "displayTime": "2025-12-16T10:38:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/supply_chain_dive_429/357f57522f7bee88bf8690911c6265c8",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2evr4Ur6pm1HKp4ztjDaqA--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/supply_chain_dive_429/357f57522f7bee88bf8690911c6265c8.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eb28oiS2Uqrq6TUHuaOiOg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/supply_chain_dive_429/357f57522f7bee88bf8690911c6265c8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Supply Chain Dive",
          "url": "https://www.supplychaindive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.supplychaindive.com/news/J-j-snack-foods-manufacturing-plant-closures-distribution-optimization-project-apollo/807916/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-snack-foods-close-103830092.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-16T10:20:00+00:00",
    "headline": "FDA ‘proactively’ hands J&J a voucher; Pfizer issues 2026 forecasts",
    "summary": "The FDA contacted J&J right after ASH to discuss using a special fast pass on a multiple myeloma regimen. Elsewhere, a new cell therapy player emerged with $60 million in Series A funding.",
    "url": "https://www.biopharmadive.com/news/tecvayli-voucher-pfizer-gilead-hiv-link-sanofi-dren/807885/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "14fe0cef-faaa-3b16-9ac1-737a10fe8e0c",
      "content": {
        "id": "14fe0cef-faaa-3b16-9ac1-737a10fe8e0c",
        "contentType": "STORY",
        "title": "FDA ‘proactively’ hands J&J a voucher; Pfizer issues 2026 forecasts",
        "description": "",
        "summary": "The FDA contacted J&J right after ASH to discuss using a special fast pass on a multiple myeloma regimen. Elsewhere, a new cell therapy player emerged with $60 million in Series A funding.",
        "pubDate": "2025-12-16T10:20:00Z",
        "displayTime": "2025-12-16T10:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YSECyFvzK8sIEiUW4LIicA--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/heEgXBvKL8Y58FXAXGaXPg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/tecvayli-voucher-pfizer-gilead-hiv-link-sanofi-dren/807885/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-proactively-hands-j-j-102000386.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "SNY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]